Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2020

Biotek-snakken — Oktober 2020

Planlagt Fastgjort Låst Flyttet Biotek-snakken
260 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bb
    wrote on sidst redigeret af
    #107

    KURA vil præsentere foreløbige data på fase 1 forsøget med Menin Inhibitor KO-539 på ASH d. 5 december. KURA stiger med ca. 7% til kurs 33,5 (ny ATH)

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #108

      God morgen...

      1 Reply Last reply
      0
      • B Offline
        B Offline
        Bisseministeren
        wrote on sidst redigeret af
        #109

        Nogen der ved hvornår handlen med curasight åbner? Den kommer på børsen i dag, men kan ikke se den på nordnet 🙂

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #110

          Tak for link BS

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #111

            For biotektosser: https://www.proinvestor.com/boards/87389/For-biotektosser

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #112

              Cantargia - Tumor shrinkage in NSCLC combination

              6 of 9 evaluable patients with metastatic NSCLC showed objective response incl 1 compl response

              The complete response has lasted more than 1 year

              Video clip :https://twitter.com/RS6HK605/status/1314109285958324225

              1 Reply Last reply
              0
              • F Offline
                F Offline
                Fandel
                wrote on sidst redigeret af
                #113

                Cantargia. Det er meget positivt Helge...

                1 Reply Last reply
                0
                • DarvinD Offline
                  DarvinD Offline
                  Darvin
                  wrote on sidst redigeret af
                  #114

                  Også interessant at BergenBio har indledt forsøg i kombi med Keytruda

                  1 Reply Last reply
                  0
                  • R Offline
                    R Offline
                    Rasbom
                    wrote on sidst redigeret af
                    #115

                    Cantargia: endnu en god nyhed fra Cantargia. De har
                    været gavmilde overfor aktionærerne den sidste måned.

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      Kaizers
                      wrote on sidst redigeret af
                      #116

                      ArcticZymes has entered into an agreement with Simcere Diagnostics to supply its HL-SAN product for Simcere’s metagenomics sequencing tests

                      Tromsø, 08 October, 2020: ArcticZymes AS, a subsidiary of ArcticZymes Technologies ASA (OSE:AZT), announces that it has entered into a supply and distribution agreement with precision medicine company Jiangsu Simcere Diagnostics, Nanjing, China for the supply of Heat-Labile Salt Active Nuclease (HL-SAN) to be used in the development and manufacturing

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        Kaizers
                        wrote on sidst redigeret af
                        #117

                        ArcticZymes Technologies ASA, CEO, Jethro Holter said: “We look forward to supporting Simcere in the development and future commercialization of their innovative sequencing assays as well as other future technologies. This is just the beginning of a long-term relationship together where ArcticZymes’ novel enzyme technologies and scientific competence will aid Simcere Diagnostics in marketing best in class sequencing technologies. The agreement marks the first step for ArcticZymes in China.

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          Kaizers
                          wrote on sidst redigeret af
                          #118

                          Simcere Diagnostics CEO, Yong Ren said:
                          “Simcere Diagnostics is excited to collaborate with ArcticZymes AS. This global collaboration not only helps Simcere in the development and commercialization of its metagenomic products, it also provides our friend ArcticZymes with a market penetration opportunity to the Chinese market. We plan to work closely in the future to explore additional means to strengthen our partnership and achieve additional penetration in China.”

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            Kaizers
                            wrote on sidst redigeret af
                            #119

                            HL-SAN is a critical component of Simcere Diagnostics’ infectious disease metagenomic assays. In particular, the nuclease supplied by ArcticZymes plays a key role in the removal of host DNA from the sample. This results in a streamlined and efficient sample preparation process that reduces background noise from the assay. Metagenomic assays are extremely sensitive to competing background noise. Fortunately, HL-SAN’s unique capability to interact with salt provides Simcere the best host DNA remov

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              Kaizers
                              wrote on sidst redigeret af
                              #120

                              removal solution available on the market.

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Rasbom
                                wrote on sidst redigeret af
                                #121

                                Tak for deling Kaizer, man kan jo næsten ikke få hænderne ned som Arcticsymes aktionær. Jeg tror virkelig vi går en kæmpe stor fremtid i møde. Hvem skulle have troede det for bare et par år tilbage...

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  Kaizers
                                  wrote on sidst redigeret af
                                  #122

                                  Nej, der lå vi med en hvis legemsdel i vandskorpen 🙂

                                  1 Reply Last reply
                                  0
                                  • L Offline
                                    L Offline
                                    lahn1
                                    wrote on sidst redigeret af
                                    #123

                                    Tak for den Kaizers. fandme godt gået af lille Biotec 🙂 Tillykke til mine alle medaktionære. Formentlig har de været kunde et stykke tid og vælger nu at basere deres produkter på AZT teknologi. Deres HL-SAN er verdens bedste ifølge Simcere Diagnostics :-o. tror vi kan se frem til flere stor-aftaler hen af vejen. De har ramt en guldåre.

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Rasbom
                                      wrote on sidst redigeret af
                                      #124

                                      Enig lahn1 jeg tror også at vi kan forvente meget mere fra AZT. Jeg holder helt sikkert på mine aktie (-:

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        lahn1
                                        wrote on sidst redigeret af
                                        #125

                                        Svært at sige hvad aftalen er værd, men det er utvivlsomt meget værd at få åbnet det kinesiske marked.

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          lahn1
                                          wrote on sidst redigeret af
                                          #126

                                          Klart behold det bliver en fin udbytte aktie om nogle år. Prissætningen hænger lidt i luften indtil vi får bekræftet vækst og indtjening, men er ret sikker på at Q3 bliver en del bedre end Q3 og så må de prøve at give en ordentlig guidning fremover.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper